Beneficial effects of Chinese herbs in the treatment of fatty liver diseases

Journal of Traditional and Complementary Medicine xxx (xxxx) xxx

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Pharmacological Research 130 (2018) 213–240

Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH)

Carotenoids: Biosynthetic and Biofunctional Approaches

Herbal drug discovery for the treatment of nonalcoholic fatty liver disease

Acta Pharmaceutica Sinica B 2020;10(1):3e18

Beneficial effects of Chinese herbs in the treatment of fatty liver diseases

Journal of Traditional and Complementary Medicine xxx (xxxx) xxx

Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease

Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health
The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease

Br J Clin Pharmacol (2017) 83 88–95

Herbal drug discovery for the treatment of nonalcoholic fatty liver disease

Acta Pharmaceutica Sinica B 2020;10(1):3e18

Herbal drug discovery for the treatment of nonalcoholic fatty liver disease

Acta Pharmaceutica Sinica B 2020;10(1):3e18

Herbal drug discovery for the treatment of nonalcoholic fatty liver disease

Acta Pharmaceutica Sinica B 2020;10(1):3e18

Herbal drug discovery for the treatment of nonalcoholic fatty liver disease

Acta Pharmaceutica Sinica B 2020;10(1):3e18

Herbal drug discovery for the treatment of nonalcoholic fatty liver disease

Acta Pharmaceutica Sinica B 2020;10(1):3e18

Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease

Pharmacological Properties of Plant-Derived Natural Products and Implications for Human Health
Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Pharmacological Research 130 (2018) 213–240

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Pharmacological Research 130 (2018) 213–240

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Pharmacological Research 130 (2018) 213–240

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Pharmacological Research 130 (2018) 213–240

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Pharmacological Research 130 (2018) 213–240

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Pharmacological Research 130 (2018) 213–240

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Pharmacological Research 130 (2018) 213–240

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Pharmacological Research 130 (2018) 213–240

Herbal medicine in the treatment of liver diseases

Digestive and Liver Disease 39 (2007) 293–304

A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis

silymarin 700 mg; Clinical Gastroenterology and Hepatology 2017;15:1940–1949

Silymarin in treatment of non-alcoholic steatohepatitis: A randomized clinical trial

Caspian J Intern Med 2014; 5(1): 9-12

A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis

silymarin 700 mg; Clinical Gastroenterology and Hepatology 2017;15:1940–1949

A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis

silymarin 700 mg; Clinical Gastroenterology and Hepatology 2017;15:1940–1949

A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis

silymarin 700 mg Clinical Gastroenterology and Hepatology 2017;15:1940–1949

The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease

Br J Clin Pharmacol (2017) 83 88–95

The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease

Br J Clin Pharmacol (2017) 83 88–95

Curcumin Attenuates Diet-Induced Hepatic Steatosis by Activating AMP-Activated Protein Kinase

Basic & Clinical Pharmacology & Toxicology, 2013, 113, 152–157

The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with
non-alcoholic fatty liver disease

European Journal of Clinical Nutrition (2019) 73:441–449

The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with
non-alcoholic fatty liver disease

European Journal of Clinical Nutrition (2019) 73:441–449

The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with
non-alcoholic fatty liver disease

European Journal of Clinical Nutrition (2019) 73:441–449

Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled
trials

Integrative Medicine Research8(2019)57–61

Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled
trials

Integrative Medicine Research8(2019)57–61

Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled
trials

Integrative Medicine Research8(2019)57–61

Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease

Mol. Nutr. Food Res. 2018, 62, 1700483

Therapeutic potential of green tea in nonalcoholic fatty liver disease

Nutrition Reviews® Vol. 70(1):41–56

Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta‐analysis of clinical trials

Phytotherapy Research. 2018;1–9

Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta‐analysis of clinical trials

Phytotherapy Research. 2018;1–9

Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta‐analysis of clinical trials

Phytotherapy Research. 2018;1–9

Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta‐analysis of clinical trials

Phytotherapy Research. 2018;1–9

Green tea as a safe alternative approach for nonalcoholic fatty liver treatment: A systematic review and meta‐analysis of clinical trials

Phytotherapy Research. 2018;1–9

Efficacy of artichoke leaf extract in non‐alcoholic fatty liver disease: A pilot double‐blind randomized controlled trial

ALE 600 mg daily or placebo Phytotherapy Research. 2018;1–6

Effect of Ginger Powder Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial

3 x 500 mg ginger Clinical and Experimental Gastroenterology 2020:13 35–45

Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver
disease: A randomized, controlled trial

400 mg GCE Complementary Therapies in Medicine 49 (2020) 102290

Effect of green coffee extract supplementation on serum adiponectin concentration and lipid profile in patients with non-alcoholic fatty liver
disease: A randomized, controlled trial

400 mg GCE Complementary Therapies in Medicine 49 (2020) 102290

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Pharmacological Research 130 (2018) 213–240

Esteatose hepática não alcoólica - fitoterapia
• Usos definidos.
• Artigos publicados
• Comprovação científica.
• Resveratrol – silimarina.
• Berberina.
• Trate igual diabetes tipo 2.
OBRIGADO